Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Q2 2025 Earnings Presentation
20 slides from Bioceres Crop Solutions's earnings presentation, Feb 12, 2025
Slide 1: Fiscal Second Quarter 2025
Fiscal Second Quarter 2025 February / 2025
Slide 2: Disclaimer
BIOCERES CROP SOLUTIONS Disclaimer Industry and Market Data Unless otherwise noted, the forecasted industry and market data contained in the assumptions for the projections are based upon the Company’s management estimates For example, other companies may calculate non-IFRS measures differently, or
Slide 3: Key Business & Financial Highlights
BIOCERES CROP SOLUTIONS Key Business & Financial Highlights ● Revenues in 2Q25 totaled $106.7 million, a 24% decline from the $140.2 million in 2Q24 ● Operating profit was $7.9 million and net income was $0.6 million. Adjusted EBITDA1 for the quarter was $15.4 million ● New strategy defined for seed
Slide 4: 2Q25 and 1H25 Results
BIOCERES CROP SOLUTIONS 2Q25 and 1H25 Results 2Q25 1H25 Regional Revenue Bridge Tight on-farm economics in Argentina ($ Million) ($ Million) Farmer income expectations from summer -22% crops limited by: • Lower soybean and corn prices Total Revenue -$236/ha1 106.7 256.8 (61.2) • Weak yield expectati
Slide 5: Revenue by Segment: Crop Protection
BIOCERES CROP SOLUTIONS Revenue by Segment: Crop Protection 2Q25 1H25 Regional Revenue Bridge 1H25 decrease fully explained by Argentina ($ Million) -29% -27% -20% BIOX YoY drop in sales of YoY drop in sales of CP in the 127.2 (29.8) CP in Argentina entire Argentine market1 2Q25 Revenue 101.1 3.7 55
Slide 6: Revenue by Segment: Crop Nutrition
BIOCERES CROP SOLUTIONS Revenue by Segment: Crop Nutrition 1H25 decrease explained by lower micro-breaded 2Q25 1H25 Regional Revenue Bridge fertilizer sales in Argentina ($ Million) -27% 75.1 (22.3) 2.2 55.0 -43% -40% BIOX YoY drop in sales of YoY drop in Argentine 2Q25 Revenue micro-beaded fertiliz
Slide 7: Revenue by Segment: Seed & Integrated Products
BIOCERES CROP SOLUTIONS Revenue by Segment: Seed & Integrated Products 2Q25 1H25 Product Revenue Bridge 1H25 decrease explained by lower HB4 downstream grain sales ($ Million) -20% In line with company’s decision to move towards a less working capital-intensive model for its HB4 program 54.5 (13.0)
Slide 8: 2Q25 Gross Profit by Segment
BIOCERES CROP SOLUTIONS 2Q25 Gross Profit by Segment ($ Million) 2Q24 2Q25 Reporting Segment Key Drivers by Segment Gross profit decline due to lower sales. Crop Gross margin for the segment was stable 51.5 45.1 - 12% YoY Protection Seed & Gross profit declined less than sales as low margin grain sa
Slide 9: 2Q25 Adjusted EBITDA
BIOCERES CROP SOLUTIONS 2Q25 2Q25 Adjusted ($ Million) EBITDA1 24.1 (5.6) (1.4) 1.0 (2.7) (1.7) 1.7 15.4 1. Please refer to “Use of non-IFRS financial information” for information Adj. EBITDA1 Crop Crop Other income Adj. EBITDA1 S&IP OPEX2 JVs regarding our use of Adjusted EBITDA and its reconciliat
Slide 10: Balance Sheet & Cash Position
BIOCERES CROP SOLUTIONS Balance Sheet 1Q25 ($ Million) 2Q25 & Cash Position ($ Million) ($ Million) Net Debt Net Debt 2.88x 3.28x Adj. EBITDA1 Adj. EBITDA1 Working Capital Efforts Significant progress reducing inventory levels by adopting a more just-in-time approach — 18% 269.5 reduction in invento
Slide 11: Bioceres Fully-Integrated Seed Business (Until Now)
BIOCERES CROP SOLUTIONS Bioceres Fully-Integrated Seed Business (Until Now) Forward Conventional Seed New Variety breeding Sales Event Selection Gene Discovery Trait Development + Seed Multiplication De-Regulation Identity Preserved Backcrossing Converted Variety Contracts Open-architecture approach
Slide 12: Re-Focused Seed Strategy
BIOCERES CROP SOLUTIONS Re-Focused Seed Strategy National Trait Managers / Broad licensing approach Event Selection Trait Development + Strategic Seed Partners / Different exclusivity levels per trait and region De-Regulation Regional Seed Developers / Franchisees Open-architecture approach, sourcin
Slide 13: Initial Actions According to New Strategy
BIOCERES CROP SOLUTIONS Initial Actions According to New Strategy Alliance with GDM to use Verdeca’s patented platform to develop and market next generation varieties 01. that combine superior agronomic performance with biotech traits. Immediate opportunity on improved weed management technology Tri
Slide 14: Unrealized Monetization Approach for Events IND-ØØ41Ø-5 and IND-ØØ412-7
BIOCERES CROP SOLUTIONS Unrealized Monetization Approach for Events IND-ØØ41Ø-5 (Soy) and IND-ØØ412-7 (Wheat) Differentiated performance of bio-activated1 soybean event IND-ØØ41Ø-5 after treatment with Glutamate Synthetase Inhibitor (GSI) Non-GM Soy Standard GM Soy IND-ØØ41Ø-5 Soy Bio-Activated1 1So
Slide 15: Milen Marinov Appointed Chief Commercial Officer
BIOCERES CROP SOLUTIONS Milen Marinov Appointed Chief Commercial Officer Position will oversee sales, marketing, business development, and portfolio management functions across the organization • Currently serving as EVP, Commercial for Since Jun 2024 North America at Bioceres/ProFarm • Former Globa
Slide 16: Exhibits
Exhibits
Slide 17: Unaudited Consolidated Statement of Comprehensive Income
BIOCERES CROP SOLUTIONS Three-month period ended Three-month period ended 12/31/2024 12/31/2023 Unaudited Revenues from contracts with customers Initial recognition and changes in the fair value of biological assets at the point of harvest 106.8 (0.1) 140.3 (0.1) Consolidated Cost of sales Gross pro
Slide 18: Unaudited Consolidated Statement of Financial Position
BIOCERES CROP SOLUTIONS ASSETS 12/31/2024 06/30/2024 LIABILITIES 12/31/2024 06/30/2024 Unaudited CURRENT ASSETS Cash and cash equivalents 29.2 44.5 CURRENT LIABILITIES Trade and other payables 144.0 168.7 Consolidated Other financial assets Trade receivables 2.0 227.7 11.7 207.3 Borrowings Employee
Slide 19: Non-IFRS Financial Measures
BIOCERES CROP SOLUTIONS Non-IFRS Financial Measures Adjusted EBITDA The company defines adjusted EBITDA as net income/(loss) exclusive of • Other companies may calculate adjusted EBITDA and similarly titled financial income/(costs), income tax benefit/(expense), depreciation, measures differently, l
Slide 20: Contact Us: Investor Relations
Contact Us: Investor Relations Investorrelations@biocerescrops.com // Investors.biocerescrops.com
Bioceres Crop Solutions — Q2 2025 Earnings Presentation on 6ix